Mark R. Seggel

417 total citations
12 papers, 327 citations indexed

About

Mark R. Seggel is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Mark R. Seggel has authored 12 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 3 papers in Pharmaceutical Science. Recurrent topics in Mark R. Seggel's work include Pharmacological Receptor Mechanisms and Effects (5 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuropeptides and Animal Physiology (3 papers). Mark R. Seggel is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (5 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuropeptides and Animal Physiology (3 papers). Mark R. Seggel collaborates with scholars based in United States and Israel. Mark R. Seggel's co-authors include Richard A. Glennon, Milt Titeler, Robert A. Lyon, William H. Soine, Kenner C. Rice, J H Woods, Gail Winger, Charles P. France, Bryan L. Roth and Fedor Medzihradsky and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and International Journal of Pharmaceutics.

In The Last Decade

Mark R. Seggel

12 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark R. Seggel United States	9	202	136	77	66	32	12	327
J. Spaide United States	12	82 0.4×	69 0.5×	77 1.0×	25 0.4×	35 1.1×	21	303
Lyon Ra United States	9	373 1.8×	226 1.7×	152 2.0×	60 0.9×	47 1.5×	20	577
D. V. Siva Sankar United States	10	78 0.4×	74 0.5×	94 1.2×	27 0.4×	34 1.1×	30	375
A. Kovács Hungary	9	121 0.6×	120 0.9×	171 2.2×	62 0.9×	11 0.3×	17	422
W. M. WELCH United States	7	219 1.1×	215 1.6×	22 0.3×	170 2.6×	21 0.7×	12	517
William H. Funderburk United States	12	206 1.0×	113 0.8×	15 0.2×	62 0.9×	47 1.5×	31	430
Anand L. Misra United States	11	173 0.9×	76 0.6×	22 0.3×	43 0.7×	68 2.1×	27	346
John H. Gogerty United States	12	90 0.4×	84 0.6×	27 0.4×	148 2.2×	25 0.8×	21	318
A. Donetti Italy	12	175 0.9×	225 1.7×	17 0.2×	214 3.2×	32 1.0×	51	499
Allan D. Rudzik United States	14	180 0.9×	165 1.2×	21 0.3×	242 3.7×	45 1.4×	43	619

Countries citing papers authored by Mark R. Seggel

Since Specialization

Citations

This map shows the geographic impact of Mark R. Seggel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Seggel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Seggel more than expected).

Fields of papers citing papers by Mark R. Seggel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Seggel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Seggel. The network helps show where Mark R. Seggel may publish in the future.

Co-authorship network of co-authors of Mark R. Seggel

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Seggel. A scholar is included among the top collaborators of Mark R. Seggel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Seggel. Mark R. Seggel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Alayoubi, Alaadin, et al.. (2020). Effects of formulation variables on the in vitro performance of testosterone transdermal gel. International Journal of Pharmaceutics. 590. 119951–119951. 3 indexed citations

Zidan, Ahmed S., Alaadin Alayoubi, Mark R. Seggel, et al.. (2017). Effect of Isopropyl Myristate on Transdermal Permeation of Testosterone From Carbopol Gel. Journal of Pharmaceutical Sciences. 106(7). 1805–1813. 30 indexed citations

France, Charles P., Gail Winger, Mark R. Seggel, Kenner C. Rice, & J H Woods. (1992). Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys. Psychopharmacology. 109(3). 291–298. 9 indexed citations

Gleeson, Suzanne, Ben Avi Weissman, Mark R. Seggel, & James E. Barrett. (1992). Neurochemical effects of 5-HT1 receptor ligands in pigeons. European Journal of Pharmacology. 229(2-3). 109–115. 17 indexed citations

Rothman, Richard B., Heng Xu, Mark R. Seggel, et al.. (1991). RTI-4614-4: An analog of (+)-cis-3-methylfentanyl with a 27,000-fold binding selectivity for mu versus delta opioid binding sites. Life Sciences. 48(23). PL111–PL116. 31 indexed citations

France, Charles P., Gail Winger, Fedor Medzihradsky, et al.. (1991). Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.. Journal of Pharmacology and Experimental Therapeutics. 258(2). 502–510. 28 indexed citations

Seggel, Mark R., et al.. (1990). A structure-affinity study of the binding of 4-substituted analogs of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors. Journal of Medicinal Chemistry. 33(3). 1032–1036. 44 indexed citations

Winger, Gail, Fedor Medzihradsky, C. B. Smith, et al.. (1990). In vitro and in vivo characterization of a fentanyl-related compound with opioid agonist and antagonist effects. 71–72. 4 indexed citations

Glennon, Richard A., et al.. (1988). Iodine-125 labeled 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors. Journal of Medicinal Chemistry. 31(1). 5–7. 90 indexed citations

10.

Titeler, Milt, et al.. (1988). Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens. European Journal of Pharmacology. 145(3). 291–297. 47 indexed citations

11.

Glennon, Richard A., Milt Titeler, Mark R. Seggel, & Robert A. Lyon. (1987). N-Methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Journal of Medicinal Chemistry. 30(5). 930–932. 18 indexed citations

12.

Seggel, Mark R., G. D. Qureshi, & Richard A. Glennon. (1987). Effect of 5-HT2-selective agonists on cat platelet aggregation. Life Sciences. 41(9). 1077–1081. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact